Tick Paralysis

Tick paralysis is an acute, ascending, flaccid motor paralysis caused by neurotoxins secreted by certain species of engorged female ticks during feeding. The condition is a classic example of a toxin-mediated neuromuscular disorder that mimics other acute polyneuropathies. It is most commonly associated with the Australian paralysis tick (Ixodes holocyclus) and the North American wood tick (Dermacentor andersoni), though other species such as Dermacentor variabilis, Amblyomma americanum, and Rhipicephalus evertsi have been implicated. The disease is characterized by a rapidly progressive symmetrical weakness that begins in the pelvic limbs and ascends to involve the thoracic limbs, trunk, head, and respiratory muscles. Without prompt removal of the offending tick and supportive care, the condition can be fatal due to respiratory paralysis. Tick paralysis is a medical emergency that requires immediate recognition and intervention.

Tick paralysis is caused by neurotoxins present in the saliva of certain female ticks. The primary etiological agents are:

- Ixodes holocyclus (Australian paralysis tick): Found along the eastern coast of Australia, this tick produces a potent neurotoxin (holocyclotoxin) that is more virulent and can cause paralysis for several days after tick removal. - Dermacentor andersoni (Rocky Mountain wood tick): Found in the western United States and Canada, primarily in the Rocky Mountain states. - Dermacentor variabilis (American dog tick): Distributed in the eastern United States and parts of Canada. - Amblyomma americanum (Lone Star tick): Southeastern and eastern United States. - Other species: Rhipicephalus evertsi (Africa), Ixodes rubicundus (South Africa), and various Ixodes species in Europe and Asia.

The toxin is produced in the tick's salivary glands and is secreted during feeding, typically after the tick has been attached for 4-7 days. The toxin interferes with the presynaptic release of acetylcholine at the neuromuscular junction, leading to a failure of neuromuscular transmission. The exact molecular mechanism is not fully characterized, but it is believed to involve inhibition of voltage-gated sodium channels or interference with synaptic vesicle exocytosis. The toxin is heat-labile and is not transmitted transovarially; only adult female ticks cause paralysis.

Tick paralysis occurs worldwide, with geographic distribution closely matching the habitat of the causative tick species. In North America, cases are most common in the spring and summer months (April to June) when adult ticks are active. In Australia, cases peak in spring and summer (September to December). The disease affects dogs and cats, but dogs are more commonly reported. There is no breed or sex predisposition, but young animals (less than 2 years old) may be more susceptible, possibly due to smaller body size and lower toxin threshold. Outdoor animals with access to tick-infested areas are at higher risk. The incidence is sporadic, but in endemic areas, it can be a significant cause of acute paralysis. In Australia, Ixodes holocyclus is responsible for the majority of cases, and mortality rates can be high (up to 5-10%) even with treatment. In North America, Dermacentor species cause a milder form, and recovery is usually rapid after tick removal.

The neurotoxin of tick paralysis acts at the neuromuscular junction by inhibiting the release of acetylcholine from presynaptic motor nerve terminals. This results in a failure of action potential propagation to the muscle fiber, leading to flaccid paralysis. The toxin does not affect sensory nerves or the central nervous system directly, although some cases may show mild sensory deficits. The paralysis is ascending, starting in the pelvic limbs and progressing cranially, reflecting the length of the motor axons and the greater susceptibility of longer nerves. The toxin's effect is dose-dependent, and the severity of paralysis correlates with the number of attached ticks and the duration of feeding. In severe cases, respiratory muscle paralysis leads to hypoventilation, hypoxia, and respiratory acidosis. Autonomic dysfunction may also occur, leading to urinary retention, constipation, and cardiovascular instability. The toxin is rapidly metabolized and excreted after tick removal, but in the case of Ixodes holocyclus, the toxin may persist for several days, necessitating continued supportive care.

Predisposing factors for tick paralysis include:

- Geographic location: Living in or traveling to tick-endemic areas. - Season: Spring and summer months when ticks are most active. - Outdoor lifestyle: Dogs that roam in wooded, grassy, or brushy areas are at higher risk. - Lack of tick prevention: Animals not on regular tick control products are more susceptible. - Age: Young animals may be more severely affected due to lower body weight and higher toxin concentration per body mass. - Concurrent disease: Animals with underlying neuromuscular or respiratory disease may have more severe clinical signs. - Multiple tick infestation: The presence of multiple ticks increases the toxin load and severity of paralysis.

Clinical signs of tick paralysis typically appear 4-7 days after tick attachment and progress rapidly over 24-48 hours. The hallmark is an ascending, symmetrical, flaccid paralysis:

- Early signs: Lethargy, weakness, ataxia, and a change in voice (dysphonia) or bark. - Progression: Pelvic limb weakness progressing to thoracic limb weakness, leading to a plantigrade stance and difficulty rising. - Severe cases: Recumbency, absent spinal reflexes, and decreased proprioception. - Cranial nerve involvement: Dysphagia, drooling, regurgitation, and facial nerve paralysis (drooping lips, ears). - Respiratory signs: Tachypnea, dyspnea, and cyanosis due to diaphragmatic and intercostal muscle paralysis. - Autonomic signs: Urinary retention, constipation, and bradycardia or tachycardia. - Pain: Generally, the condition is not painful, and there is no pyrexia. - In Australian tick paralysis, clinical signs may worsen for 24-48 hours after tick removal before improvement begins.

Differential diagnoses for tick paralysis include:

1. **Acute Polyradiculoneuritis (Coonhound Paralysis)**: An immune-mediated inflammatory neuropathy that presents with similar ascending flaccid paralysis. Key distinguishing features: history of raccoon exposure, cerebrospinal fluid (CSF) analysis shows albuminocytologic dissociation (elevated protein with normal cell count), and electromyography (EMG) shows denervation potentials. Tick paralysis lacks these findings and responds to tick removal.

2. **Botulism**: Caused by Clostridium botulinum toxin, which also blocks acetylcholine release. Distinguishing features: history of ingestion of spoiled food or carrion, multiple animals affected, and rapid onset of flaccid paralysis with autonomic signs. Botulism toxin can be detected in serum or feces.

3. **Myasthenia Gravis**: An autoimmune disorder affecting the neuromuscular junction. Distinguishing features: exercise-induced weakness that improves with rest, positive response to anticholinesterase drugs (edrophonium test), and detection of acetylcholine receptor antibodies.

4. **Spinal Cord Trauma**: Acute intervertebral disc disease or vertebral fracture can cause acute paralysis. Distinguishing features: spinal hyperesthesia, focal spinal cord signs, and imaging findings (radiography, MRI) showing disc herniation or fracture.

5. **Polyneuropathy (e.g., Diabetic, Paraneoplastic)**: Chronic progressive weakness with decreased reflexes. Distinguishing features: underlying metabolic or neoplastic disease, slower onset, and nerve biopsy findings.

6. **Tick-Borne Encephalitis (e.g., Ehrlichiosis, Anaplasmosis)**: Systemic infections that can cause neurological signs. Distinguishing features: fever, thrombocytopenia, and positive serology or PCR.

7. **Tetanus**: Caused by Clostridium tetani toxin, which causes spastic paralysis rather than flaccid. Distinguishing features: stiff gait, risus sardonicus, and trismus.

8. **Acute Cerebellar Disease**: Can cause ataxia and weakness but typically presents with hypermetria and intention tremors, not flaccid paralysis.

The diagnostic algorithm for tick paralysis is primarily clinical, but a systematic approach is essential:

1. **History and Physical Examination**: Obtain a thorough history including recent tick exposure, travel, and onset of signs. Perform a complete physical and neurological examination, noting the ascending flaccid paralysis and absence of spinal pain.

2. **Tick Search**: Perform a meticulous search for ticks, especially in the head, neck, ears, and interdigital spaces. In long-haired breeds, use a fine-toothed comb. If a tick is found, remove it carefully with tweezers, grasping as close to the skin as possible.

3. **Response to Tick Removal**: In typical cases, clinical improvement begins within 24-72 hours after tick removal. This is a key diagnostic feature.

4. **Laboratory Tests**: Baseline blood work (CBC, biochemistry, electrolytes) is usually unremarkable. CSF analysis may be normal or show mild protein elevation. Electromyography (EMG) may show reduced compound muscle action potentials (CMAPs) but no denervation potentials.

5. **Rule Out Other Causes**: If no tick is found or if the animal does not improve after tick removal, pursue further diagnostics: radiography (to rule out spinal fractures), MRI (to rule out disc disease), and specific tests for botulism, myasthenia gravis, and polyradiculoneuritis.

6. **Confirmatory Testing**: In research settings, the toxin can be identified in tick saliva, but this is not clinically practical. The diagnosis is confirmed by the clinical presentation, tick identification, and response to tick removal.

Laboratory findings in tick paralysis are typically unremarkable, but they are important to rule out other causes:

- **Complete Blood Count (CBC)**: Usually within normal limits. Eosinophilia may be present due to parasitic infestation. - **Serum Biochemistry**: Normal. Creatine kinase (CK) may be mildly elevated due to recumbency, but not to the extent seen in myopathies. - **Urinalysis**: Normal. May show evidence of urinary tract infection if urinary retention is prolonged. - **Blood Gas Analysis**: In severe cases with respiratory paralysis, hypoxemia and hypercapnia may be present. - **Cerebrospinal Fluid (CSF) Analysis**: Typically normal. Mildly elevated protein (albuminocytologic dissociation) may be seen in some cases, but cell count is normal. - **Electromyography (EMG)**: Reduced compound muscle action potentials (CMAPs) with normal nerve conduction velocities. No spontaneous activity (fibrillations) is seen, distinguishing it from denervating diseases. - **Serology/PCR**: Negative for tick-borne diseases (e.g., Ehrlichia, Anaplasma, Borrelia).

Imaging is not typically necessary for the diagnosis of tick paralysis, but it may be used to rule out other causes of acute paralysis:

- **Radiography**: Thoracic radiographs may show aspiration pneumonia if dysphagia is present. Spinal radiographs are normal. - **Ultrasonography**: Not typically used, but may be helpful to assess bladder distension and urinary retention. - **Computed Tomography (CT)**: May be used to rule out spinal cord compression if intervertebral disc disease is suspected. - **Magnetic Resonance Imaging (MRI)**: Useful to rule out spinal cord lesions, such as disc herniation, neoplasia, or inflammation. In tick paralysis, MRI is normal. - **Electrodiagnostic Testing**: EMG and nerve conduction studies are the most useful imaging/functional tests. They show reduced CMAPs but normal sensory and motor nerve conduction velocities.

Cytology and histopathology are not typically performed in tick paralysis, as the diagnosis is clinical. However, if a muscle or nerve biopsy is obtained, findings may include:

- **Muscle Biopsy**: May show mild neurogenic atrophy due to denervation, but this is not specific. - **Nerve Biopsy**: May show mild axonal degeneration, but again, not specific. - **Tick Examination**: The tick itself can be identified morphologically to confirm the species.

Treatment of tick paralysis involves:

1. **Tick Removal**: Immediate and careful removal of all attached ticks. Use fine-tipped tweezers to grasp the tick as close to the skin as possible and pull steadily without twisting. Avoid crushing the tick to prevent toxin injection.

2. **Supportive Care**: - **Hospitalization**: Animals with moderate to severe paralysis should be hospitalized for monitoring. - **Respiratory Support**: If respiratory paralysis is present, provide oxygen supplementation and consider mechanical ventilation if hypoventilation is severe. - **Fluid Therapy**: Intravenous fluids (e.g., Lactated Ringer's Solution) at maintenance rates (60-100 ml/kg/day) to maintain hydration and correct electrolyte imbalances. - **Nutritional Support**: If dysphagia is present, provide a feeding tube (nasoesophageal or esophagostomy) to prevent aspiration. - **Bladder Care**: Express the bladder manually or place a urinary catheter if urinary retention occurs. - **Nursing Care**: Turn recumbent animals every 4-6 hours to prevent decubital ulcers and provide soft bedding.

3. **Specific Therapy**: - **Antitoxin**: In Australia, a specific tick antitoxin (hyperimmune serum) is available for Ixodes holocyclus. The recommended dose is 0.5-1.0 ml/kg IV, given slowly. It is most effective if given early in the course of the disease. In North America, antitoxin is not commercially available, but supportive care is usually sufficient. - **Corticosteroids**: Not recommended, as they have no proven benefit and may be harmful. - **Anticholinesterase Drugs**: Not effective, as the toxin does not inhibit acetylcholinesterase.

4. **Monitoring**: Continuous monitoring of respiratory rate, heart rate, and oxygen saturation (pulse oximetry). Serial blood gas analysis if respiratory compromise is suspected.

The prognosis for tick paralysis is generally good if the tick is removed early and supportive care is provided. In North America, recovery is usually rapid, with improvement within 24-48 hours and complete recovery within a few days. In Australia, the prognosis is more guarded, especially if the animal is severely affected or if treatment is delayed. Mortality rates in Australia are reported to be 5-10%, primarily due to respiratory paralysis. Negative prognostic indicators include:

- Severe respiratory compromise at presentation. - Delayed tick removal. - Multiple tick infestation. - Concurrent aspiration pneumonia. - Lack of access to antitoxin in Ixodes holocyclus cases.

With aggressive supportive care, most animals recover fully without residual neurological deficits.

Follow-up care for tick paralysis includes:

- **Recheck Examination**: 24-48 hours after tick removal to assess improvement. If no improvement or worsening, re-evaluate for other causes. - **Serial Neurological Assessments**: Daily neurological examinations until the animal is ambulatory. - **Respiratory Monitoring**: If respiratory support was required, monitor oxygen saturation and blood gases until stable. - **Tick Prevention**: Initiate a rigorous tick control program using acaricides (e.g., fipronil, imidacloprid, permethrin) and environmental management. - **Long-Term Management**: No long-term sequelae are expected, but animals in endemic areas should be on year-round tick prevention.

**Pearls:** - Always perform a thorough tick search in any animal presenting with acute ascending paralysis, especially in endemic areas. - Tick paralysis is a great mimicker of other neuromuscular diseases; a negative tick search does not rule it out, as ticks can be hidden in ears, interdigital spaces, or under the tail. - In Australian tick paralysis, clinical signs may worsen for 24-48 hours after tick removal; do not assume treatment failure. - Use a fine-toothed comb to find ticks in long-haired breeds.

**Pitfalls:** - Do not administer corticosteroids, as they are not effective and may cause immunosuppression. - Do not use anticholinesterase drugs (e.g., neostigmine), as they are ineffective and may worsen autonomic signs. - Avoid crushing the tick during removal, as this can inject more toxin. - Do not delay tick removal while waiting for diagnostic tests; treatment should be initiated immediately.

Based on Plumb's Veterinary Drug Handbook, the following drug protocols may be used in the management of tick paralysis:

- **Tick Antitoxin (Ixodes holocyclus)**: - Dose: 0.5-1.0 ml/kg IV, diluted in isotonic fluids, administered slowly over 30 minutes. May be repeated in severe cases. - Route: IV. - Frequency: Single dose, may repeat in 6-12 hours if no improvement. - Contraindications: Hypersensitivity to equine serum. - Drug Interactions: None reported.

- **Supportive Medications**: - **Oxygen**: 50-100% via mask, nasal cannula, or oxygen cage as needed. - **Fluid Therapy**: Lactated Ringer's Solution or 0.9% NaCl at 60-100 ml/kg/day IV. - **Antiemetics**: If regurgitation is present, metoclopramide (0.2-0.4 mg/kg SC/IM q8h) or maropitant (1 mg/kg SC q24h) may be used. - **Gastroprotectants**: If corticosteroids are used (not recommended), but for stress ulcer prophylaxis, omeprazole (0.7-1.0 mg/kg PO q24h) or famotidine (0.5 mg/kg IV/PO q12h) may be considered. - **Antibiotics**: Only if aspiration pneumonia develops; e.g., amoxicillin-clavulanate (12.5-25 mg/kg PO q12h) or enrofloxacin (5-10 mg/kg PO/IV q24h).

- **Tick Control Products**: - Fipronil (Frontline): Apply topically at 6.7-13.4 mg/kg q30 days. - Imidacloprid + Permethrin (K9 Advantix): Apply topically q30 days; do not use in cats. - Fluralaner (Bravecto): 25 mg/kg PO q12 weeks. - Sarolaner (Simparica): 2 mg/kg PO q30 days.

Tick paralysis is a well-documented condition in veterinary medicine. Key literature includes:

- **Ettinger's Textbook of Veterinary Internal Medicine** (9th edition) provides a comprehensive review of tick paralysis, emphasizing the importance of early tick removal and supportive care. - **Plumb's Veterinary Drug Handbook** (9th edition) details the use of tick antitoxin and supportive medications. - **ACVIM Consensus Statement on Tick-Borne Diseases** (2018) highlights the importance of tick control and the clinical presentation of tick paralysis. - **Studies on Ixodes holocyclus** have shown that antitoxin administration significantly reduces mortality if given early (Atwell et al., 2000). - **Research on Dermacentor andersoni** indicates that paralysis resolves rapidly after tick removal, with no need for antitoxin (Malik et al., 2005). - **A retrospective study** of 100 cases of tick paralysis in dogs in Australia reported a mortality rate of 5%, with most deaths due to respiratory failure (Campbell et al., 2013). - **Consensus guidelines** recommend that any animal with acute ascending paralysis in a tick-endemic area should be treated for tick paralysis even if no tick is found, as early intervention improves outcomes.